[1] Kemp EH, Waterman EA, Gawkrodger DJ, et al. Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Bri J Dermatol, 1998, 139: 798- 805. [2] Okamoto T, Irie RF, Fujii S, et al. Antityrosinase related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol, 1998, 111(6): 1034-1039. [3] Baharav E, Merimski O, Shoenfeld Y, et al. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol, 1996, 105(1): 84-88. [4] Song YH, Connor E, Li Y, et al.The role of tyrosinase in autoimmune vitiligo. Lancet, 1994, 344(8929): 1049-1052. [5] 关翠萍,周妙妮,李永伟等. 人酪氨酸酶抗原表位肽的表达、纯化及在白癜风患者中的抗原性检测. 中华医学杂志,2007,87(34):2408-2411. [6] Farrokhi S, Farsangi-Hojjat M, Noohpisheh MK, et al. Assessment of the immune system in 55 Iranian patients with vitiligo. J Eur Acad Dermatol Venereol, 2005, 19(6): 706-711. [7] Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol, 1991, 97(6): 1078-1080. [8] Naughton GK, Reggiardo MD, Bystryn JC. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol, 1986, 15: 978-981. [9] Rezaei N, Gavalas NG, Weetman AP, et al. Autoimmunity as an aetiological factor in vitiligo. JEADV, 2007, 21: 968-976. [10] 洪为松, 尉晓冬, 周渭珩, 等. 血清中抗酪氨酸酶抗体的检测与白癜风活动性的关系. 中国麻风皮肤病杂志, 2005, 21(9): 682-684. [11] 关翠萍,陈斐斐,周妙妮,等. 三种表达肽检测进展期白癜风患者血清酪氨酸酶抗体的比较. 中华皮肤科杂志,2009,42(10):15-18. |